Curate Curate Biosciences (Formerly GPB Scientific)
2023 GPB Scientific Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance
ILiAD Biotechnologies
2022 ILiAD Biotechnologies Announces Publication of BPZE1 Adult Phase 2b Clinical Results in The Lancet
ILiAD Biotechnologies
2022 ILiAD Biotechnologies Announces $42.8M Financing Round to Advance BPZE1 Pertussis Vaccine
Curate Curate Biosciences (Formerly GPB Scientific)
ILiAD Biotechnologies
2021 ILiAD Biotechnologies closes a $23.9 million Convertible Note Offering
ILiAD Biotechnologies
Seneca Therapeutics
June 2020 Seneca Therapeutics closed a $3 million Series A round.
Curate Curate Biosciences (Formerly GPB Scientific)
2020 GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Read the full press release
ILiAD Biotechnologies
2019-2020 ILiAD Biotechnologies Secures Up to $20 million of Financing and Phase 2a BPZE1 Pertussis Vaccine Trial Initiates at Vanderbilt University Medical Center
Read the full press release
Seneca Therapeutics
2019-2020 Seneca Therapeutics closed on a $780,000 KISS financing
ILiAD Biotechnologies
June 2019 ILIAD Biotechnologies BPZE1 vaccine mentioned in CNN Report: Whooping cough vaccine becomes less effective over time, study says
Seneca Therapeutics
2019 Seneca Therapeutics closed on a $500,000 KISS financing
GPB Scientific
2018 GPB Scientific closes $2.5 million convertible note round
FORGE Life Sciences
Fall 2017 FORGE Life Sciences raises $500,000 from angel investors
Illuminare Biotechnologies
Summer 2017 Illuminare Biotechnologies closed a $2.3M Series A round
ILiAD Biotechnologies
July 2017 ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study Data
Read the full press release...
RenalSense
2017-2018 RenalSense raises $3.5 million from angel investors
GPB Scientific
2017 GPB Scientific raises $1.0 million from angel investors
ILiAD Biotechnologies
2016-2017 ILiAD Biotechnologies raises $2.6 million from angel investors
GPB Scientific
Spring 2016 GPB Scientific raises $1.0 million from angel investors.
ILiAD Biotechnologies
Spring 2016 ILiAD Biotechnologies raises $1.0 million from angel investors.
GPB Scientific
Fall 2015 GPB Scientific closes $1.6 million Series A round.
RenalSense
Fall 2015 RenalSense closes $3.6 million Series A round.
ILiAD Biotechnologies
Fall 2015 ILiAD Biotechnologies closes $3.7 million financing round.
CytoSorbents Corporation
March 2014 CytoSorbents Corporation Announces $10.2 Million Registered Direct Offering.
Click here to read the full press release
GPB Scientific
March 2014 GPB Scientific raises $700,000 from angel investors.
Callidus Biopharma
November 2013 Callidus Biopharma acquired by Amicus Therapeutics (NASDAQ-FOLD) for $15 million upfront payment with potential milestone payments totaling $115 million. Click here to read the full press release
Hygeia Therapeutics
November 2013 Hygeia Therapeutics acquired by Stratus Media Group (OTCBB-SMDI).
Click here to read the full press release
CytoSorbents
October 2013 CytoSorbents raises $200,000 from angel investors.
Callidus Biopharma
May 2013 Callidus Biopharma announces $4.6 million Series A financing
Read the full press release
Callidus Biopharma
March 2013 Callidus Biopharma receives $3.0 million from strategic investors
Callidus Biopharma
December 2012 Callidus Biopharma successfully generates in vivo proof of concept data
Callidus Biopharma
January 2012 Callidus Biopharma receives $1.6 million from Angel and strategic investors
Core Essence Orthopaedics
October 2011 Core Essence Orthopaedics launches PONTiS™, a novel endotendonous implant for minimally invasive repair of severed tendons
Lerner Medical Devices
September 2011 Lerner Medical Devices closes on a $1M Angel financing
Advanced BioHealing
July 2011 Advanced BioHealing Acquired by Shire Pharmaceuticals for $750M
WuXi PharmaTech
June 2011 WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise by China's Ministry of Commerce
Core Essence Orthopaedics
March 2011 Core Essence Orthopaedics receives an $11.3M Series B round led by Baird Venture Partners
WuXi PharmaTech
March 2011 WuXi PharmaTech announces collaboration with BMS for a new analytical and stability testing facility
Core Essence Orthopaedics
October 2010 Core Essence Orthopaedics closes on a $2.9M Convertible Debt from Angel Investors
QuantumBio and Chemical Computing Group
May 2011 QuantumBio and Chemical Computing Group announce release of DivCon Discovery Suite for MOE
Hygeia Therapeutics
March 2010 Hygeia Therapeutics closes on a $2.0M round from Angel Investors
Lerner Medical Devices
November 2009 Lerner Medical Devices receives 510(k) clearance for Levia® Targeted Phototherapy for Self-Treatment at home
WuXi PharmaTech
October 2009 WuXi PharmaTech receives 2009 Schering-Plough Excellence Award
MedAvante
Lerner Medical Devices
December 2007 Lerner Medical Devices closes on a $3.3M Angel Round to develop Levia® device
WuXi PharmaTech
2007 WuXi PharmaTech publicily listed in NYSE. Read More